Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abuse Potential and Human Pharmacology of Methylone
NCT05488171Phase 1Unknown
- Sponsor
- Hospital Universitari Germans Trias i Pujol
- Start
- Dec 2021
- Primary completion
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1 trial of methylone (3 arms), sponsored by Hospital Universitari Germans Trias i Pujol. Primary endpoint: Maximum effect (Emax) in blood pressure at 24 hours. Status: unknown.
02
Drugs
methylone
Beyond the preview
Go deeper on NCT05488171.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05488171.